Phase I study of the preventive effect of Kampo medicine on oxaliplatin-induced peripheral neurotoxicity
Not Applicable
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000016085
- Lead Sponsor
- Wakayama Medical University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1.having resistance for using Kampo 2. chemotherapy using oxaliplatin has been performed 3.having double cancer 4.having serious sensory disturbance 5.having serious drug hypersensitivity 6. having serious infection 7. having serious psycho-neurologic disease 8.having serious complication as follows: uncontrorable diabetes mellitus, uncontrorable hypertension, interstitial pneumonia or pulmonary fibrosis, ileus, and serious heart disease 9. inappropriate judgment for study by clinical investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method